检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘娟[1] 吴和英[1] 谭宗建[1] 张红云[1] 张勇[1] 邓丽萍(编辑)[1]
机构地区:[1]贵州省人民医院生殖中心,贵州贵阳,550002
出 处:《医学临床研究》2012年第8期1488-1490,共3页Journal of Clinical Research
摘 要:【目的】了解反复自然流产(RSA)患者封闭抗体(BA)的水平,并观察淋巴细胞免疫治疗的临床效果。【方法】用酶联免疫吸附试验测定218例RSA患者BA水平,并对其中198例BA阴性患者进行淋巴细胞免疫治疗,疗程结束后复查BA,追踪BA转阳后妊娠情况,评估免疫治疗的临床效果。【结果]218例RSA患者中BA阴性率为90.8%(198/218),198例BA阴性患者经淋巴细胞免疫治疗1个疗程后,BA阳性率为61.1%,2个疗程后阳性率为78.3%,3个疗程后阳性率为86.4%,BA阳性率与治疗前比较差异均有显著性(P〈O.05);198例免疫治疗的患者中,有164例再次妊娠,其中138例获妊娠成功,26例再次发生早期自然流产,妊娠成功率为84.2%,与治疗前比较差异具有显著性(P〈o.05)。【结论】RsA患者BA阴性率高,用淋巴细胞免疫治疗可提高RSA患者的BA阳性率,淋巴细胞免疫治疗是一种治疗BA不足引起RSA的安全、有效的方法。[Objective]To understand the level of blocking antibody(BA) in patients with recurrent sponta- neous abortion(RSA), and observe the clinical efficacy of lymphocyte active immunotherapy. [Methods]The level of BA in 218 patients with RSA were detected by enzyme linked immunosorbent assay. Among all pa- tients, 198 patients with BA-negative received lymphocyte active immunotherapy. After the treatment, the level of BA was reexamined. Pregnancy outcomes were traced after the positive conversion of BA. Clinical effi- cacy of immunotherapy was evaluated. [Results]The negative rate of BA in 218 patients with RSA was 90.8~/6o (198/218). After one course of lymphocyte active immunotherapy, the positive rate of 198 patients with gA- negative was 61.1%. After two courses of therapy, the positive rate was 78.30/60. After three courses of ther- apy, the positive rate was 86.40/00. There was significant difference in the positive rate of BA between before and after treatment( P d0.05). Among 198 patients receiving immunotherapy, 164 patients were pregnant a- gain in which 138 patients were successfully pregnant and 26 patients had the recurrence of early spontaneous abortion. The successful rate of pregnancy was 84.2~, and there was significant difference between before and after treatment( P d0.05). [Conclusion]The negative rate of BA in patients with RSA is high. Lympho- cyte active immunotherapy can improve the positive rate of BA in patients with RSA. Lymphocyte active im- munotherapy is a safe and effective method for the treatment of RSA caused by the lack of BA.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117